Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)NCT06568367AXSMPhase 3Recruiting2026-12Estimated
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)NCT06568627MDWDPhase 3Recruiting2026-12Estimated
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerNCT06568692Processa PharmaceuticalsPhase 2Terminated2026-07-29Actual
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs PlaceboNCT06577090SKYEPhase 2Active not recruiting2026-11-20Estimated
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaNCT06581406Replimune, Inc.Phase 2, Phase 3Recruiting2030-01Estimated
Performance of the Travoprost Intraocular ImplantNCT06582732Glaukos CorporationPhase 2Completed2023-11-02Actual
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic DermatitisNCT06585202ACRSPhase 2Completed2025-03-13Actual
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque PsoriasisNCT06586112ALMSPhase 3Completed2025-09-19Actual
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person SyndromeNCT06588491Kyverna TherapeuticsPhase 2Completed2026-06-25Actual
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.NCT06588686Vicore Pharma ABPhase 2Active not recruiting2027-05Estimated
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001NCT06588738ALMSPhase 3Completed2025-09-23Actual
Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentNCT06590090XBITPhase 2Not yet recruiting2027-01-15Estimated
Open-Label Extension Study of SetmelanotideNCT06596135RYTMPhase 3Completed2026-06-24Actual
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)NCT06602193DNLIPhase 2Active not recruiting2027-03Estimated
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271Ensysce BiosciencesPhase 3Recruiting2026-08Estimated
A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaNCT06603077AVTXPhase 2Completed2026-02-23Actual
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible UrticariaNCT06603220EVMNPhase 2Completed2025-05-08Actual
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant DiseaseNCT06607458DCTHPhase 2Recruiting2026-12Estimated
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaNCT06608927RCUSPhase 3Active not recruiting2030-11-30Estimated
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)NCT06615557VTGNPhase 3Completed2026-04-21Actual
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974Tectonic TherapeuticPhase 2Active not recruiting2026-11-24Estimated
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)NCT06617429RAREPhase 3Terminated2026-07-10Actual
Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisNCT06619990XNCRPhase 1, Phase 2Recruiting2027-12Estimated
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)NCT06625320RVMDPhase 3Active not recruiting2026-06Estimated
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaNCT06628947KPRXPhase 2Recruiting2027-08Estimated
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)NCT06629402Ensysce BiosciencesPhase 2Completed2023-11-14Actual
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)NCT06634420Intellia TherapeuticsPhase 3Active not recruiting2026-02-10Actual
Setrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaNCT06636071RAREPhase 3Active not recruiting2027-01Estimated
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainNCT06637527OKYOPhase 2Terminated2025-04-30Actual
A Study of Olverembatinib in SDH-deficient GIST.NCT06640361Ascentage Pharma Group Inc.Phase 3Recruiting2027-03-31Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.